LoadingLoadingLoadingThe quick read
Latest quote·Oct 14
Net selling: insiders sold $4M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $15K to $50K in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsNet selling: insiders sold $4M and bought $0 of ICLR stock on the open market in the 90 days to Oct 16, 2026, according to SEC Form 4 filings. The largest was Climax, John Dr (Director), who sold $1M. The latest filing was on Sep 18, 2026.
Rep. Kevin Hern (R) sold $15K to $50K on Aug 14, 2026, disclosed 18 days later. In total, 1 member disclosed 1 ICLR trade with trade dates in the last 180 days, filed a median 18 days after trading.
This summary uses filings available on Oct 16, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
8 funds hold a position and insiders have been net selling.
Buys/Adds (1)
Point72
$62.5M
added
Sells/Trims (2)
Sachem Head
$232.9M
sold
Impactive Capital
$49.9M
sold
No tracked top-trader positions in ICLR right now.
Live Hyperliquid positioning - not every stock is covered
Last report
Jul 29, 2026
Period ending
Jun 30, 2026
Earnings per share
$2.26 expected
Revenue
No reported revenue on record
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | $2.35 / $2.26Alpha Vantage | +3.98% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 27, 2026 | $2.22 / $2.16Alpha Vantage | +2.78% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 25, 2026 | $2.52 / $3.31Alpha Vantage | -23.87% miss | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 22, 2025 | $3.31 / $3.28Alpha Vantage | +0.91% in line | Unavailable | Unavailable |
| Jun 30, 2025 | Jul 23, 2025 | $3.26 / $3.18Alpha Vantage | +2.52% beat | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 30, 2025 | $3.19 / $3.09Alpha Vantage | +3.24% beat | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 19, 2025 | $3.43 / $3.43Alpha Vantage | +0.14% in line | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 23, 2024 | $3.35 / $3.84Alpha Vantage | -12.76% miss | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Estimates as of Oct 15, 2026
EPS expected
$2.56 to $2.70
Revenue expected
14 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Richly priced and running thin margins.
Valuation
Quality
Growth
This stock is trending upward.
Trend
Constructive
65 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
